Literature DB >> 22104151

Synthesis, anticancer activity and apoptosis inducing ability of bisindole linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.

Ahmed Kamal1, Y V V Srikanth, M Janaki Ramaiah, M Naseer Ahmed Khan, M Kashi Reddy, Md Ashraf, A Lavanya, S N C V L Pushpavalli, Manika Pal-Bhadra.   

Abstract

A series of bisindole-pyrrolobenzodiazepine conjugates (5a-f) linked through different alkane spacers was prepared and evaluated for their anticancer activity. All compounds exhibited significant anticancer potency and the most potent compounds 5b and 5e were taken up for detailed studies on MCF-7 cell line. Cell cycle effects were examined apart from investigating the inhibition of tubulin polymerization for compounds 2a, 2b, 5b and 5e at 2μM. FACS analysis showed that at higher concentrations (4 and 8μM) there was an increase of sub-G1 phase cells and decrease of G2/M phase cells, thus indicating that compounds 5b and 5e are effective in causing apoptosis in MCF-7 cells. It was also observed that compounds 5b and 5e showed the down regulation of histone deacetylase protein levels such as HDAC1, 2, 3, 8 and increase in the levels of p21, followed by apoptotic cell death. The apoptotic nature of these compounds was further evidenced by increased expression of cleaved-PARP and active caspase-7 in MCF-7 cells.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104151     DOI: 10.1016/j.bmcl.2011.10.080

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Bisindole-PBD regulates breast cancer cell proliferation via SIRT-p53 axis.

Authors:  Pranjal Sarma; Indira Bag; M Janaki Ramaiah; Ahmed Kamal; Utpal Bhadra; Manika Pal Bhadra
Journal:  Cancer Biol Ther       Date:  2015-07-20       Impact factor: 4.742

2.  Anti-cancer activity of novel dibenzo[b,f]azepine tethered isoxazoline derivatives.

Authors:  Maralinganadoddi Panchegowda Sadashiva; Shivananju NanjundaSwamy; Feng Li; Kanjoormana Aryan Manu; Murugan Sengottuvelan; Doddakunche Shivaramu Prasanna; Nirvanappa Chikkagundagal Anilkumar; Gautam Sethi; Kazuyuki Sugahara; Kanchugarakoppal Subbegowda Rangappa
Journal:  BMC Chem Biol       Date:  2012-10-03

3.  Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with Indole-Containing Cap Group.

Authors:  Yingjie Zhang; Penghui Yang; C James Chou; Chunxi Liu; Xuejian Wang; Wenfang Xu
Journal:  ACS Med Chem Lett       Date:  2013-01-08       Impact factor: 4.345

4.  A novel bisindole-PBD conjugate causes DNA damage induced apoptosis via inhibition of DNA repair pathway.

Authors:  Pranjal Sarma; M Janaki Ramaiah; Ahmed Kamal; Utpal Bhadra; Manika Pal Bhadra
Journal:  Cancer Biol Ther       Date:  2014-07-10       Impact factor: 4.742

5.  Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.

Authors:  Sandip B Bharate; Jaideep B Bharate; Shabana I Khan; Babu L Tekwani; Melissa R Jacob; Ramesh Mudududdla; Rammohan R Yadav; Baljinder Singh; P R Sharma; Sudip Maity; Baldev Singh; Ikhlas A Khan; Ram A Vishwakarma
Journal:  Eur J Med Chem       Date:  2013-02-28       Impact factor: 6.514

6.  Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation.

Authors:  Wagdy M Eldehna; Mahmoud F Abo-Ashour; Hany S Ibrahim; Ghada H Al-Ansary; Hazem A Ghabbour; Mahmoud M Elaasser; Hanaa Y A Ahmed; Nesreen A Safwat
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

7.  Synthesis, anti-leishmanial and molecular docking study of bis-indole derivatives.

Authors:  Muhammad Taha; Imad Uddin; Mohammed Gollapalli; Noor Barak Almandil; Fazal Rahim; Rai Khalid Farooq; Muhammad Nawaz; Mohamed Ibrahim; Mohammed A Alqahtani; Yasser A Bamarouf; Manikandan Selvaraj
Journal:  BMC Chem       Date:  2019-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.